Xinhua News Agency, Chongqing, March 27 (Reporter Wu Yanxia) Chinese researchers have recently made new progress in the field of cerebral hemorrhage research, and found that strengthening blood pressure in the ultra-early stage can improve the treatment effect of cerebral hemorrhage and the accuracy of predicting consequences. This is for cerebral hemorrhage. Clinical treatment and scientific research have brought new directions.
As one of the important advances in the field of cerebral hemorrhage in 2020, related research results have been included in the "2020 Acute Stroke Treatment Progress Special Report" by the international academic journal "Stroke".
Li Qi, the first author of the paper and associate professor of the Department of Neurology at the First Affiliated Hospital of Chongqing Medical University, said that previous studies have shown that intensive antihypertensive treatment is not beneficial to control the expansion of hematoma or improve the poor prognosis of patients.
However, clinical studies have found that most hematoma enlargement occurs within 2 to 3 hours of the onset of symptoms, rather than 24 hours as traditionally believed.
In response to this discovery, Li Qi came to Harvard University to repeatedly compare different blood pressure reduction programs for patients with cerebral hemorrhage, and put forward the concept of "intracerebral hemorrhage anti-hematoma expansion treatment time window", and found that strengthening blood pressure in the ultra-early stage can reduce the risk of hematoma expansion Help predict the severity of illness.
The research was published in the international academic journal "The Annals of Neurology" and was affirmed by the authoritative international stroke expert group. Li Qi was also invited to participate in the first European Stroke Society-World Stroke Society Joint Conference and introduced the experience of treating cerebral hemorrhage within the ultra-early treatment time window.